Galderma Group N
Swiss Stock Exchange GALD.SW
Galderma Group N Operating Cash Flow for the year ending December 31, 2023: USD 165.23 M
Galderma Group N Operating Cash Flow is USD 165.23 M for the year ending December 31, 2023, a 43.74% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Galderma Group N Operating Cash Flow for the year ending December 31, 2022 was USD 114.95 M, a -41.39% change year over year.
-
Galderma Group N Operating Cash Flow for the year ending December 31, 2021 was USD 196.12 M.
Key data
| Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
|---|
Market news
Loading...
Swiss Stock Exchange: GALD.SW
| CEO | Dr. Flemming Ornskov M.B.A., M.P.H. |
| IPO Date | March 21, 2024 |
| Location | Switzerland |
| Headquarters | Zählerweg 10 |
| Employees | 6,545 |
| Sector | Consumer Discretionary |
| Industries | |
Description
Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email